Gaithersburg-based GlycoMimetics Inc. set the terms for its upcoming IPO on Monday, planning to sell 4 million shares at between $14 and $16 apiece.
The biotech expects to list on the NASDAQ under the ticker symbol GLYC. It would be the third in an already active stretch for Maryland life sciences IPOs, following Intrexon Corp. and MacroGenics Inc. to the public markets.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2013/10/glycomimetics-sets-ipo-price-range-at.html{/iframe}